Cysview FDA Approval History
FDA Approved: Yes (First approved May 28, 2010)
Brand name: Cysview
Generic name: hexaminolevulinate
Dosage form: for Intravesical Solution
Previous Name: Hexvix
Company: Photocure ASA
Treatment for: Diagnosis and Investigation
Cysview (hexaminolevulinate HCl) is an optical imaging agent indicated for use in the cystoscopic detection of non-muscle invasive papillary cancer of the bladder.
Development Timeline for Cysview
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.